SYRINGE POSIFLUSH 5ml FILL 4% SODIUM CITRATE LOCK USP BX/30

box of 30

Maximize catheter patency, minimize risk. 67% reduction in systemic bleeding events (7 vs 21; p = 0.035) with no risk of heparin-induced thrombocytopenia.6. Significantly fewer CRBSI with 4% sodium citrate vs 5,000 U/mL heparin (0.81 vs 1.90/1,000 catheter-days, p = 0.026). Efficiently inhibits biofilm formation and cell growth of S. aureus and S. epidermidis.